InvestorsHub Logo
Followers 132
Posts 6427
Boards Moderated 0
Alias Born 05/13/2014

Re: None

Thursday, 10/08/2020 8:19:53 AM

Thursday, October 08, 2020 8:19:53 AM

Post# of 44690
Maybe some Easter Eggs in here? ... I like the language...

Raghuram (Ram) Selvaraju, Chairman of the Board, said:

“We are delighted to have Jack join the Relief team. His broad expertise will be invaluable to the Company at a time when RLF-100TM outpaces traditional clinical development timelines to meet the necessary requirements to demonstrate safety and efficacy data in the treatment of severely ill COVID-19 patients. His regulatory and public company experience will be critical in our intensive interactions with regulatory authorities and our increasing dialogue with the investment community in order to raise awareness and understanding of Relief. I very much look forward to working with him."

ALSO I like this note from the new CFO himself:

“I am impressed by how swiftly Relief reacted to one of the largest healthcare disasters of our time by rapidly advancing their proprietary asset into clinical development and towards approval. I am excited to join the Company at a stage when it is evolving and growing to meet a major unmet medical need with a potentially lifesaving treatment for severely sick COVID-19 patients,"


SOUNDS to me like all of this was done ... uhh ... like .... YESTERDAY ;)


https://finance.yahoo.com/news/relief-therapeutics-appoints-industry-veteran-051000105.html